C12N 9/94
Pancreatin
C12N9/94 (Pancreatin) appears on 26 US grants and 42 published applications in this corpus.
Search patents in C12N- Granted patents
- 26
- Published applications
- 42
- Assignees
- 28
- Inventors
- 109
- Latest grant
- 9 Apr 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 2 |
| 2008 | 0 | 2 |
| 2009 | 0 | 2 |
| 2010 | 0 | 0 |
| 2011 | 1 | 1 |
| 2012 | 1 | 1 |
| 2013 | 0 | 0 |
| 2014 | 2 | 2 |
| 2015 | 3 | 2 |
| 2016 | 1 | 5 |
| 2017 | 1 | 4 |
| 2018 | 2 | 6 |
| 2019 | 4 | 2 |
| 2020 | 1 | 5 |
| 2021 | 1 | 0 |
| 2022 | 2 | 2 |
| 2023 | 0 | 0 |
| 2024 | 1 | 2 |
| 2025 | 0 | 3 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for reducing or inactivating viral and microbial content in the processes for the manufacture of pancreatin9 Apr 2024US 11,952,603 B2Scientific Protein Laboratories, LLC
- Zinc-charged pancreatic enzymes for treatment of cancer and inflammation28 Jun 2022US 11,371,037 B1America Great Health
- Enzyme compositions with reduced viral and microbial contamination22 Mar 2022US 11,278,603 B2AbbVie Inc.
- Composition and methods of use17 Aug 2021US 11,091,380 B2
- Processes for the manufacture and use of pancreatin7 Jul 2020US 10,704,037 B2
- Performance-enhanced protease variants x12 Feb 2026US 2026/0043015 A1Henkel AG & Co. KGaA
- Enzyme compositions with reduced viral and microbial contamination13 Nov 2025US 2025/0345405 A1AbbVie Inc.
- High potency pancreatin pharmaceutical compositions23 Oct 2025US 2025/0327059 A1Allergan Pharmaceuticals International Limited
- Methods for decellularizing human omentum and products generated therefrom18 Sep 2025US 2025/0290036 A1Matricelf Ltd.
- Enzyme compositions with reduced viral and microbial contamination26 Dec 2024US 2024/0424070 A1AbbVie Inc.
Most cited
By later US patents
- Isolation of pancreatin62US 4,623,624 ABASF SE · 1986
- Methods of treating and diagnosing Parkinsons disease and related dysautonomic disorders49US 8,012,710 B2Curemark, LLC · 2011
- Method of treating and diagnosing Parkinson's disease and related dysautonomic disorders34US 9,233,146 B2Curemark, LLC · 2016
- Methods of treating and diagnosing Parkinson's disease and related dysautonomic disorders29US 8,778,335 B2Curemark, LLC · 2014
- Continuous process of producing pancreatin and product thereof21US 4,019,958 AKali-Chemie Pharma GmbH · 1977